Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03226808 · ClinicalTrials.gov registry record · NA

Vivacit-E Post-market Follow-up Study

A NA study of Osteoarthritis and Post-traumatic; Arthrosis, sponsored by Zimmer Biomet.

Active
Registry status
NA
Development phase
258
Enrollment target
5
Study locations

NCT03226808 is a NA study of Osteoarthritis and Post-traumatic; Arthrosis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 258 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (68% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03226808, a NA study of Osteoarthritis and Post-traumatic; Arthrosis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
258 participants
Enrollment target
5
Study locations

Study Summary

The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

Interventions

  • DEVICE Vivacit-E Liner

Study Locations (5)

North Carolina

  • Department of Orthopaedics University of North Carolina at Chapel Hill - Chapel Hill
  • OrthoCarolina Research Institute - Charlotte

Colorado

  • Denver Hip and Knee, Inc. - Parker

Pennsylvania

  • Rothman Institute - Philadelphia

Texas

  • Texas Institute for Hip and Knee Surgery - Austin

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2013-10-01
Est. Completion 2028-06-30
Phase NA

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT03226808

The ClinicalTrials.gov registry entry for NCT03226808 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (68% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Vivacit-E Liner is the first listed.

NCT03226808 reports 5 study locations spanning 4 distinct geographic areas - top geographies include North Carolina, Colorado, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03226808 about?

NCT03226808 is a clinical study titled "Vivacit-E Post-market Follow-up Study". The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

What is the current status of trial NCT03226808?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 258 participants. The study started on 2013-10-01. Estimated completion is 2028-06-30.

What conditions does trial NCT03226808 study?

This clinical trial studies the following conditions: Osteoarthritis, Post-traumatic; Arthrosis, Congenital Hip Dysplasia, Avascular Necrosis of Bone of Hip.

What interventions are being tested in trial NCT03226808?

The interventions under investigation include: Vivacit-E Liner (DEVICE).

Who is sponsoring clinical trial NCT03226808?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03226808 being conducted?

This trial has 5 study locations across Colorado, North Carolina, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.